HCP satisfaction and psoriasis control are greater with biologics, so what’s the barrier?

Psoriasis In America 2019, a Health Union survey of 1,211 people diagnosed with psoriasis, aimed to uncover the intricacies of living with psoriasis including navigating treatment decisions and managing their overall health and wellness. The survey findings reveal a shift to greater use of biologics and small molecule medications and shed light on the barriers that still exist for many patients when it comes to considering these types of treatment options.